ArticleProceedings of the National Academy of Sciences of the United States of America2020

Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.

Hsin-Yu Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.